2024 eCQMs
For the 2024 performance year, Sevocity offers workflows and reports for 20 eCQMs Electronic Clinical Quality Measure, quality measures that use data from EHRs or Health IT systems.
Workflows have been developed to assist Sevocity users with the 2024 electronic clinical quality measures. Although there may be other methods capable of meeting the measures, only the recommended workflows are approved to meet the measure requirements within Sevocity.
These workflows are designed as a supplemental resource and are not a substitute for the eligibility and requirements of the programs for which the eCQMs are being reported.
Active Diagnosis: an ICD‑9 or ICD‑10 code added in the Assessment tab of an encounter which has neither been resolved nor inactivated
Eligible Clinician (EC): a Medicare provider who qualifies for MIPS participation
Eligible Encounter: an encounter finalized by the EC that qualifies a patient for a measure denominator based on coding, timing, or other specified criteria
Measurement Period: for the 2024 performance year, the Measurement Period is defined as January 1, 2024 through December 31, 2024
CMS 2v13: Preventive Care and Screening: Screening for Depression and Follow-Up Plan
CMS 50v12: Closing the Referral Loop: Receipt of Specialist Report
CMS 68v13: Documentation of Current Medications in the Medical Record
CMS 117v12: Childhood Immunization Status
CMS 122v12: Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%)
CMS 124v12: Cervical Cancer Screening
CMS 131v12: Diabetes: Eye Exam
CMS 138v12: Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
CMS 139v12: Falls: Screening for Future Fall Risk
CMS 146v12: Appropriate Testing for Pharyngitis
CMS 149v12: Dementia: Cognitive Assessment
CMS 153v12: Chlamydia Screening in Women
CMS 154v12: Appropriate Treatment for Upper Respiratory Infection (URI)
CMS 156v12: Use of High-Risk Medications in Older Adults
CMS 159v12: Depression Remission at Twelve Months
CMS 165v12: Controlling High Blood Pressure
CMS 347v7: Statin Therapy for the Prevention and Treatment of Cardiovascular Disease
CMS 951v2: Kidney Health Evaluation
Didn't find the answer you were looking for?
Contact Sevocity Support 24/7 at 877‑777‑2298 or support@sevocity.com